PCM
ZYNE

Prelude Capital Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Prelude Capital Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,769
Closed -$6K – 1981
2020
Q2 		$6K Buy
+1,769
New +$6K ﹤0.01% 1153
2016
Q3 		– Sell
-2,000
Closed -$14K – 1808
2016
Q2 		$14K Buy
+2,000
New +$14K ﹤0.01% 1301